Opportunity Information: Apply for CDC RFA DD12 1206
Apply for CDC RFA DD12 1206
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Hemoglobinopathies Surveillance, Health Promotion, and Laboratory Capacity Demonstration Project" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.184 Disabilities Prevention.
- This funding opportunity was created on Mar 30, 2012 and posted on Mar 30, 2012.
- Applicants must submit their applications by May 30, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,200,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $250,000.00 in funding.
- The number of recipients for this funding is limited to 3 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- A state governmental agency, its bona fide agent or its equivalent, as designated by the Governor, Health Office, or other state executive as the official applicant for this program. For this announcement, the term State includes the 50 states, the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Hemoglobinopathies Surveillance, Health Promotion, and Laboratory Capacity Demonstration Project (Funding Opportunity Number CDC RFA DD12-1206) was a Centers for Disease Control and Prevention (CDC) cooperative agreement designed to build on the earlier Registry and Surveillance for Hemoglobinopathies (RuSH) initiative. Its main goal was to expand and strengthen state-based efforts related to hemoglobinopathies (inherited blood disorders such as sickle cell disease and thalassemias) while aligning that work with the Healthy People 2020 focus area on Blood Disorders and Blood Safety. Rather than being limited to data collection alone, the opportunity was framed as a demonstration project, meaning funded recipients were expected to show workable, scalable approaches that could inform broader public health practice.
The project emphasized three connected areas. First, it focused on public health surveillance, supporting states in improving how they identify, track, and understand hemoglobinopathy-affected populations over time. This includes building or enhancing registry-like functions, using reliable case definitions, and strengthening the ability to describe disease burden, outcomes, and service needs across communities. Second, it supported health promotion and prevention awareness activities, reflecting the idea that better data should translate into better public-facing education, targeted outreach, and prevention-oriented messaging for affected individuals, families, and providers. Third, it aimed to build laboratory capacity, recognizing that hemoglobinopathy surveillance and care depend heavily on accurate testing, confirmatory diagnostics, and strong laboratory systems that can support population-level monitoring and quality assurance.
Administratively, this was a discretionary funding opportunity using a cooperative agreement mechanism, which typically means CDC would have substantial involvement beyond simply issuing funds, such as providing technical assistance, coordination, or shared implementation expectations. The total estimated funding amount was 1,200,000 dollars, with an expected three awards. The listed award ceiling was 250,000 dollars per award (with no stated award floor), and there was no cost sharing or matching requirement.
Eligibility was limited to state governmental agencies (or their bona fide agents or equivalents) officially designated by a governor, health office, or other state executive authority. The announcement defined "state" broadly to include not only the 50 states, but also the District of Columbia and multiple U.S. territories and freely associated states, including Puerto Rico, the U.S. Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau. The program was associated with CFDA 93.184 under Disabilities Prevention.
The opportunity was posted March 30, 2012, with an application closing date of May 30, 2012, and it was archived June 29, 2012. For access issues or submission-related questions at the time, CDC directed applicants to contact the Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS), via the provided phone line (770-488-2700).
Frequently Asked Questions (FAQs)
What is the full name of this funding opportunity?
The opportunity was titled the Hemoglobinopathies Surveillance, Health Promotion, and Laboratory Capacity Demonstration Project.
What is the Funding Opportunity Number (FONO)?
The Funding Opportunity Number was CDC RFA DD12-1206.
Which federal agency offered this opportunity?
This opportunity was offered by the Centers for Disease Control and Prevention (CDC).
What type of funding mechanism was used?
It was a CDC cooperative agreement, described as a discretionary funding opportunity.
What does it mean that this was a cooperative agreement?
A cooperative agreement generally indicates CDC would have substantial involvement beyond issuing funds, such as providing technical assistance, coordination, or shared implementation expectations.
What was the overall purpose of the project?
The main goal was to expand and strengthen state-based efforts related to hemoglobinopathies (inherited blood disorders such as sickle cell disease and thalassemias) and align that work with the Healthy People 2020 focus area on Blood Disorders and Blood Safety.
How did this project relate to the earlier RuSH initiative?
It was designed to build on the earlier Registry and Surveillance for Hemoglobinopathies (RuSH) initiative.
Why was this described as a "demonstration project"?
Because funded recipients were expected to demonstrate workable, scalable approaches that could inform broader public health practice, rather than focusing only on data collection.
What health conditions were the focus of this opportunity?
The focus was on hemoglobinopathies, described as inherited blood disorders such as sickle cell disease and thalassemias.
What were the three major program emphasis areas?
The project emphasized three connected areas: (1) public health surveillance, (2) health promotion and prevention awareness activities, and (3) laboratory capacity building.
What kinds of activities were included under public health surveillance?
Surveillance efforts included improving how states identify, track, and understand hemoglobinopathy-affected populations over time, including building or enhancing registry-like functions, using reliable case definitions, and strengthening the ability to describe disease burden, outcomes, and service needs across communities.
What was meant by health promotion and prevention awareness activities?
The opportunity emphasized that better data should translate into education and outreach, including public-facing education, targeted outreach, and prevention-oriented messaging for affected individuals, families, and providers.
What did "laboratory capacity" refer to in this project?
Laboratory capacity focused on accurate testing, confirmatory diagnostics, and strong laboratory systems that support population-level monitoring and quality assurance for hemoglobinopathy surveillance and care.
Who was eligible to apply?
Eligibility was limited to state governmental agencies (or their bona fide agents or equivalents) that were officially designated by a governor, health office, or other state executive authority.
How was the term "state" defined for eligibility purposes?
"State" was defined broadly to include the 50 states, the District of Columbia, and certain U.S. territories and freely associated states.
Which territories and freely associated states were explicitly included?
The announcement included Puerto Rico, the U.S. Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau.
What was the total estimated funding amount?
The total estimated funding amount was $1,200,000.
How many awards were expected?
CDC expected to make three awards.
What was the maximum award amount (award ceiling) per recipient?
The listed award ceiling was $250,000 per award.
Was there a minimum award amount (award floor)?
No award floor was stated in the provided information.
Was cost sharing or matching required?
No cost sharing or matching requirement was listed.
What CFDA number was associated with this program?
The opportunity was associated with CFDA 93.184 under Disabilities Prevention.
When was the opportunity posted?
The opportunity was posted on March 30, 2012.
What was the application closing date?
The application closing date was May 30, 2012.
When was the opportunity archived?
The opportunity was archived on June 29, 2012.
Who could applicants contact for access issues or submission-related questions?
CDC directed applicants to contact the Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS).
What phone number was provided for applicant support?
The phone line provided was 770-488-2700.
Browse more opportunities from the same category: Health
Next opportunity: Office of Small Business Development Centers Program Announcement for the State of Connecticut (CT)
Previous opportunity: Health Systems Strengthening Project (HSSP)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DD12 1206
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DD12 1206) also looked into and applied for these:
| Funding Opportunity |
|---|
| Cooperative Research Agreements Related Apply for PAR 12 126 Funding Number: PAR 12 126 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| To Strengthen Collaboration between CDC and the National TB Controllers and the National TB Nurse Coalition Apply for CDC RFA PS12 1205 Funding Number: CDC RFA PS12 1205 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $230,000 |
| Implementing a National Framework to Eliminate Mother to Child HIV Transmission in the United States Apply for CDC RFA PS12 1206 Funding Number: CDC RFA PS12 1206 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $424,500 |
| Nurse Education, Practice, Quality and Retention (NEPQR) Program Interprofessional Collaborative Practice Apply for HRSA 12 060 Funding Number: HRSA 12 060 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Centers of Excellence for Research on CAM (P01) Apply for PAR 12 151 Funding Number: PAR 12 151 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Combating Autism Act Initiative National Interdisciplinary Training Resource Center Apply for HRSA 12 155 Funding Number: HRSA 12 155 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Emergency Medical Services for Children Data Coordinating Center Apply for HRSA 12 044 Funding Number: HRSA 12 044 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Republic of the Marshall Islands Special Medical Care and Logistics Apply for DE FOA 0000711 Funding Number: DE FOA 0000711 Agency: Headquarters Category: Health Funding Amount: $19,000,000 |
| Engaging Local Non Governmental Organizations (NGOs) in the Provision of High Quality HIV Care and Treatment to Vulnerable Populations in Southwestern and Western China under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1233 Funding Number: CDC RFA GH12 1233 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Comprehensive Facility Based Technical Assistance in the Context of Health Systems Strengthening in South Africa under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1257 Funding Number: CDC RFA GH12 1257 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $25,000,000 |
| Serve as the U.S. partner within the global STOP TB Partnership and participate in Stop TB Partnership activities. Apply for CDC RFA PS12 1208 Funding Number: CDC RFA PS12 1208 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| Genomic Medicine Pilot Demonstration Projects Coordinating Center (U01) Apply for RFA HG 12 007 Funding Number: RFA HG 12 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Genomic Medicine Pilot Demonstration Projects (U01) Apply for RFA HG 12 006 Funding Number: RFA HG 12 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01) Apply for PAR 12 152 Funding Number: PAR 12 152 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of a Vestibular Neural Prosthesis (R01) Apply for RFA DC 13 001 Funding Number: RFA DC 13 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Comprehensive District Based Support for Better HIV/TB Patient Outcomes Apply for RFA 674 12 000005 DRAFT RFA Funding Number: RFA 674 12 000005 DRAFT RFA Agency: South Africa USAID Pretoria Category: Health Funding Amount: $20,000,000 |
| Limited Competition NHLBI Research Centers at Minority Serving Institutions Phase II (P50) Apply for RFA HL 13 011 Funding Number: RFA HL 13 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Electronic Learning (E Learning) Collaborative Resource Center for SV and IPV Prevention Practitioners Apply for CDC RFA CE12 1204 Funding Number: CDC RFA CE12 1204 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $415,000 |
| Research and Technical Assistance for Public Health Laboratories in Haiti to support post earthquake reconstruction, cholera and HIV/AIDS response Apply for RFA GH 12 002 Funding Number: RFA GH 12 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Support Services for Orphans and Vulnerable Children in Nyanza and Rift Valley Provinces, Kenya, through Local Kenyan Organizations Apply for RFA 615 12 000004 Funding Number: RFA 615 12 000004 Agency: Kenya USAID Nairobi Category: Health Funding Amount: $2,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DD12 1206", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.